A newly published study shows that the risk of long COVID has dropped during the pandemic due to COVID vaccines. Moreover, metabolic and gastrointestinal sequelae increased among the unvaccinated.
This provides more solid evidence of the value of vaccination against COVID. Not that I needed more convincing.
Let’s examine the study and determine what it says about the COVID vaccines and the risk of long COVID.

What is long COVID?
Post-acute sequelae of SARS-CoV-2 infection (PASC), also called long-haul COVID or simply, long COVID, are conditions, including, but not limited to, neuropsychiatric, digestive, pulmonary, cardiovascular, and diabetes. These conditions persist long after the SARS-CoV-2 infection has passed. There is no test to diagnose long COVID conditions, and some individuals may have a wide variety of symptoms that could result from prior health conditions but are exacerbated by COVID. This can make it difficult for healthcare providers to recognize post-COVID conditions.
Worse yet, since the symptoms are difficult to explain, they are often tough to manage. There is no known “cure” for long COVID, so healthcare professionals have to focus on treating the symptoms, not a favorite technique of most science-based physicians.
Some people love to point out that the vast majority of people survive a COVID-19 infection (while ignoring the large number, over 1 million in the USA alone, that have died). However, they fail to consider long-COVID, which may have more serious complications than the initial COVID-19 infection itself.
By September 2023, the CDC estimated that 7% of all American adults had experienced long COVID at some point.
Let me make this point again — COVID-19 vaccines reduce the risk of serious disease complications including developing long COVID-19.

Long COVID and vaccines research
In a paper published on 17 July 2024 in the respected New England Journal of Medicine, Ziyad Al-Aly, MD, VA St. Louis Health Care System, Missouri, and colleagues analyzed health records of 441,583 veterans who were diagnosed with COVID-19 infection between March 2020 and the end of January 2022 and also included over 4.7 million non-infected controls.
The study included five cohorts that included unvaccinated people with COVID-19 infected with the original strain in 2020 (n=206,011), the Delta variant in 2021 (n=54,002), and the Omicron variant in 2022 (n=40,367), and vaccinated people infected with the Delta variant (n=56,260) or the Omicron variant (n=84,943).
This study qualifies as “large” given the huge number of health records that were analyzed during each of the variant eras that hit during the pandemic.
Here are the key results of this study:
- During the pre-Delta era, there were 10.42 cases of long COVID per 100 unvaccinated people at 1 year after COVID-19 infection, decreasing to 9.51 cases during the Delta variant era, and dropping to 7.76 cases per 100 unvaccinated people during the Omicron era.
- During the Delta era, there were 5.34 cases of long COVID per 100 vaccinated people one year after infection.
- During the Omicron era, there were 3.5 cases per 100 vaccinated people one year after infection.
- The researchers stated that about 72% of the decrease in the cumulative risk of long COVID between the Omicron era and earlier eras could be attributed to vaccines and about 28% could be attributed to era-related effects, such as changes in virus pathogenicity.
The authors concluded:
The cumulative incidence of PASC during the first year after SARS-CoV-2 infection decreased over the course of the pandemic, but the risk of PASC remained substantial even among vaccinated persons who had SARS-CoV-2 infection in the omicron era.
Summary
Although this study provides us with strong evidence that vaccination reduces the risk of long COVID there are some limitations to this study. First, the study included primarily older white male US military veterans. Second, the study did not evaluate data on long COVID after January 2022. Finally, the study may have missed some confounding variables that may have biased the data.
That being said, the study provides strong evidence that individuals who receive COVID vaccines have a significantly lower risk of developing long COVID. This also provides more powerful evidence regarding the effectiveness of the vaccine.
Citations
- Xie Y, Choi T, Al-Aly Z. Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras. N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211. Epub ahead of print. PMID: 39018527.
Discover more from Skeptical Raptor
Subscribe to get the latest posts sent to your email.
